Stock listing

Dusseldorf:1SP Surgery Partners, Inc. Aktie

German listing (Dusseldorf) of Surgery Partners, Inc. · home listing NASDAQ:SGRY

Follow Surgery Partners, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:SGRY

$26.78 USD -0.18 (-0.7%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:SGRY

Past year +75.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$26.64 – $26.96 USDNov 20, 2026
Volume
1.11M sharesNov 20, 2026
Market cap
$3.50B USDAt the close on Nov 20, 2026 · price × 130.9M shares outstanding
52-week range
$11.41 – $27.23 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$78.52M USDMedian day 2.27M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Surgery Partners, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:SGRY · Home$26.78 USD-0.18 (-0.7%)1,111,621$26.65$26.96$26.64$26.96Close on Nov 20, 2026
Frankfurt:1SP€24.20 EUR0.00 (0.0%)—€24.00€24.20€24.00€24.20Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:SGRY · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$26.78-0.18-0.7%$26.65$26.96$26.641,111,621
$26.96+0.11+0.4%$26.85$27.07$26.803,237,982
$26.85+0.06+0.2%$26.68$26.89$26.682,034,137
$26.79-0.16-0.6%$26.75$26.95$26.621,607,414
$26.95+0.37+1.4%$26.65$26.95$26.603,138,835
$26.58-0.08-0.3%$26.68$26.81$26.563,466,913
$26.66-0.07-0.3%$26.40$26.70$26.392,607,566
$26.73+0.28+1.1%$26.71$26.82$26.337,306,324
$26.45+3.25+14.0%$25.81$27.23$25.7717,048,983
$23.20+0.03+0.1%$23.17$23.23$23.172,824,370
$23.17+0.010.0%$23.23$23.24$23.135,785,470
$23.16+0.03+0.1%$23.20$23.27$23.1410,927,979
$23.13+0.010.0%$23.19$23.22$23.122,274,876
$23.12-0.09-0.4%$23.21$23.23$23.123,367,555
$23.210.000.0%$23.24$23.25$23.193,513,600
$23.21-0.03-0.1%$23.25$23.28$23.173,535,000
$23.24-0.12-0.5%$23.26$23.36$23.203,105,500
$23.36+0.11+0.5%$23.20$23.37$23.1311,199,300
$23.25+7.50+47.6%$23.03$23.29$22.9458,815,500
$15.75-0.15-0.9%$15.79$16.16$15.663,332,400
$15.90+0.50+3.2%$15.52$16.00$15.352,906,300
$15.40-0.09-0.6%$15.19$15.64$15.072,355,400
$15.49+0.78+5.3%$14.77$15.52$14.774,323,200
$14.71+0.10+0.7%$14.57$14.89$14.491,306,400
$14.61-0.16-1.1%$14.86$14.90$14.51966,800
$14.77-0.06-0.4%$15.05$15.34$14.622,369,500
$14.83+0.28+1.9%$14.46$14.84$14.091,440,100
$14.55+0.31+2.2%$14.35$14.77$14.261,137,700
$14.24+0.35+2.5%$13.85$14.32$13.681,212,400
$13.89+0.25+1.8%$13.69$14.06$13.61929,000
$13.64-0.07-0.5%$13.58$13.71$13.351,314,900
$13.71+0.30+2.2%$13.36$13.97$13.341,685,900
$13.41+0.08+0.6%$13.43$13.57$13.22892,300
$13.33+0.01+0.1%$13.26$13.50$13.161,566,800
$13.32+0.09+0.7%$13.35$13.55$13.111,228,100
$13.23-0.64-4.6%$13.81$14.28$13.141,874,300
$13.87-0.54-3.7%$14.32$14.42$13.861,857,200
$14.41-0.28-1.9%$14.65$14.78$14.251,421,000
$14.69+0.29+2.0%$14.18$14.71$14.141,103,800
$14.40+0.20+1.4%$14.22$14.67$14.191,762,800
$14.20-0.36-2.5%$14.38$14.52$13.982,029,400
$14.56-1.24-7.8%$15.72$15.84$14.433,723,600
$15.80+2.14+15.7%$13.79$15.90$13.678,109,000
$13.66+0.41+3.1%$13.41$13.74$13.092,311,500
$13.25-0.10-0.7%$13.12$13.49$12.972,763,800
$13.35-0.58-4.2%$14.10$14.15$13.263,806,200
$13.93+0.28+2.1%$13.71$14.24$13.601,477,100
$13.65-0.39-2.8%$13.97$14.16$13.561,911,200
$14.04-0.34-2.4%$14.44$14.73$14.022,162,300
$14.38+0.26+1.8%$14.23$14.60$14.031,288,000
$14.120.000.0%$14.10$14.18$13.723,275,300
$14.12+0.16+1.1%$13.87$14.49$13.591,680,000
$13.96-0.30-2.1%$14.19$14.41$13.902,046,100
$14.26+0.09+0.6%$14.17$14.51$14.061,106,600
$14.17+0.19+1.4%$14.13$14.37$13.881,634,200
$13.98-0.62-4.2%$14.58$14.72$13.912,212,900
$14.60+0.71+5.1%$13.89$15.08$13.783,962,500
$13.89+0.20+1.5%$13.65$13.93$13.183,922,200
$13.69-0.24-1.7%$13.87$13.98$13.522,039,000
$13.93-0.11-0.8%$13.90$14.10$13.681,371,800
$14.04-0.01-0.1%$14.01$14.39$14.003,297,500
$14.05+0.10+0.7%$13.75$14.08$13.752,274,300
$13.95-0.57-3.9%$14.55$14.80$13.922,148,100
$14.52+0.58+4.2%$14.10$14.55$13.793,876,200
$13.94+0.34+2.5%$13.99$14.17$13.526,397,900
Ticker
Dusseldorf:1SP
Asset type
Stock
Sector
Health care
Industry
Health care services
Exchange
Dusseldorf
Currency
EUR

What changed lately

Latest news

All Surgery Partners, Inc. news

Surgery Partners, Inc. on 6ix

Sector
Health care
Industry
Health care services
News releases
21 in the last 12 months · 98 in all · newest Nov 20, 2026 · oldest 2019
Calls
21 calls with a replay · 21 with a transcript · latest Aug 10, 2026
Decks
19 decks · latest Aug 10, 2026

Where Surgery Partners, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:SGRY · Home listingNASDAQUnited StatesUSD
LS Exchange:A14YWPLS ExchangeGermanyEUR
Lang & Schwarz:A14YWPLang & SchwarzGermanyEUR
gettex:1SPgettexGermanyEUR
Tradegate:1SPTradegateGermanyEUR
BOATS:SGRYBOATSUnited StatesUSD
Frankfurt:1SPFrankfurtGermanyEUR
Dusseldorf:1SP · This pageDusseldorfGermanyEUR
Munich:1SPMunichGermanyEUR
Stuttgart:1SPStuttgartGermanyEUR

Valuation

EV/sales 1.9× against a median of 2.0×: 5th lowest of 11 Health care services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$6.21B USD
P/E
Loss
EV/sales
1.9×
EV/EBITDA
11.5×
Price/book
2.1×
Gross margin
21.1%
Operating margin
10.8%
Net margin
−2.6%
Debt to equity
1.8×
Beta vs S&P 500
0.94

Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Surgery Partners, Inc. · NASDAQ:SGRYUS$3.50BUS$6.21Bn/a1.9×11.5×2.1×−2.6%1.8×0.94
Jointown Pharmaceutical Group Co., Ltd. Class A · SSE:600998US$3.91BUS$755.9M13.3×0.0×n/a0.9×1.1%0.1×n/a
Doximity, Inc. · NYSE:DOCSUS$3.66BUS$2.95B26.2×4.5×15.3×3.9×21.1%0.0×0.74
Dr. Lal PathLabs Limited · NSE:LALPATHLABUS$3.62BUS$3.47B57.5×10.6×36.0×12.2×19.2%0.1×n/a
Krishna Institute of Medical Sciences Limited · NSE:KIMSUS$3.61BUS$3.93B157×7.9×41.0×8.5×4.6%0.9×n/a
Hims & Hers Health, Inc. · NYSE:HIMSUS$3.30BUS$4.15Bn/a1.4×n/a9.3×−6.7%4.4×2.64
Acadia Healthcare Company, Inc. · NASDAQ:ACHCUS$3.22BUS$5.41Bn/a1.6×10.1×1.6×−33.1%1.2×0.82
Privia Health Group, Inc. · NASDAQ:PRVAUS$3.20BUS$2.76B92.1×1.1×43.3×3.9×1.4%0.0×0.23
National HealthCare Corporation · AMEX:NHCUS$2.99BUS$3.27B26.1×2.1×16.0×2.7×7.2%0.5×0.37
Guardian Pharmacy Services, Inc. · NYSE:GRDNUS$2.97BUS$2.86B39.8×2.0×24.3×10.6×5.1%0.0×0.70
Inventurus Knowledge Solutions Limited · NSE:IKSUS$2.97BUS$2.97B36.0×8.2×23.3×9.8×22.8%0.0×n/a
Median of the othersUS$3.26BUS$3.12B37.9×2.0×23.8×6.2×4.9%0.1×0.72

Forecasts

1 strong buy · 6 hold · Analysts' consensus from EODHD, read Nov 12, 2026. Not 6ix's view and not investment advice.

Price target
22.90 USD · Analysts' mean
EPS, year to Dec 2026
0.29 · 4 analysts
Revenue, year to Dec 2026
3.19B · 6 analysts

Team and board

Officers

OfficerRole
Eric EvansChief Executive Officer
Kristi JensenMarket CEO (Northeast) and Enterprise Operational Excellence
Noah ClevengerMarket CEO (Illinois) and Enterprise Preferred Vascular
Dave DohertyExecutive Vice President – Chief Financial Officer
Mike MaleyWest Division, President
Justin OppenheimerExecutive Vice President – Chief Operating Officer
J. Spencer ClarkSenior Vice President – General Counsel
Kelly T. WhelanSenior Vice President – General Counsel
Brent JacobsSenior Vice President – Acquisitions and Development
Cameron EadesSenior Vice President – Controller
Danielle BurkhalterExecutive Vice President – Chief People and Transformation Officer
Dawn CastroSenior Vice President – Chief Revenue Cycle Officer
Jackie WrightSenior Vice President – Chief Procurement Officer
Jane VanderbiltSenior Vice President – Business Operations
Jennifer BaldockExecutive Vice President – Chief Administrative and Development Officer
Jon FredricksonSenior Vice President – Chief Information Officer
Marissa BrittenhamExecutive Vice President – Chief Strategy Officer
Patrick BrownSenior Vice President – Market Growth and Business Development
Roxanne WomackSenior Vice President – Chief Compliance Officer
Shannon YarrowSenior Vice President – Managed Care
Sid SoonasraSenior Vice President - Physician Practice and Anesthesia Operations
Steven CornelisonSenior Vice President – Treasurer
Tamala Norris-McJunkinsSenior Vice President – Enterprise Chief Clinical Officer
Jeremy ClarkNorth Division, President
Trent WebbSouth Division, President

Board

DirectorRole
Lloyd DeanDirector

Events

Calls

CallWhenStatus
Surgery Partners (NASDAQ:SGRY) Q2 2026 Earnings CallMon, Aug 10, 2026 · 8:30 AM ETReplay
Surgery Partners (NASDAQ:SGRY) Q1 2026 Earnings CallTue, May 05, 2026 · 8:30 AM ETReplay
Surgery Partners (NASDAQ:SGRY) Q4 2025 Earnings CallTue, Mar 03, 2026 · 8:30 AM ETReplay
Surgery Partners (NASDAQ:SGRY) Q3 2025 Earnings CallMon, Nov 10, 2025 · 8:30 AM ETReplay
Surgery Partners (NASDAQ:SGRY) Q2 2025 Earnings CallTue, Aug 05, 2025 · 8:30 AM ETReplay
Surgery Partners (NASDAQ:SGRY) Q1 2025 Earnings CallMon, May 12, 2025 · 8:30 AM ETReplay
Surgery Partners (NASDAQ:SGRY) Q4 2024 Earnings CallMon, Mar 03, 2025 · 8:30 AM ETReplay
Surgery Partners (NASDAQ:SGRY) Q3 2024 Earnings CallTue, Nov 12, 2024 · 8:30 AM ETReplay
Surgery Partners (NASDAQ:SGRY) Q2 2024 Earnings CallTue, Aug 06, 2024 · 8:30 AM ETReplay
Surgery Partners (NASDAQ:SGRY) Q1 2024 Earnings CallTue, May 07, 2024 · 8:30 AM ETReplay
All 21 calls
CallWhenStatus
Surgery Partners (NASDAQ:SGRY) Q4 2023 Earnings CallMon, Feb 26, 2024 · 8:30 AM ETReplay
Surgery Partners (NASDAQ:SGRY) Q3 2023 Earnings CallTue, Nov 07, 2023 · 8:30 AM ETReplay
Surgery Partners (NASDAQ:SGRY) Q2 2023 Earnings CallTue, Aug 01, 2023 · 8:30 AM ETReplay
Surgery Partners (NASDAQ:SGRY) Q1 2023 Earnings CallMon, May 01, 2023 · 5:00 PM ETReplay
Surgery Partners (NASDAQ:SGRY) Q4 2022 Earnings CallWed, Mar 01, 2023 · 8:30 AM ETReplay
Surgery Partners (NASDAQ:SGRY) Q3 2022 Earnings CallTue, Nov 08, 2022 · 8:30 AM ETReplay
Surgery Partners (NASDAQ:SGRY) Q2 2022 Earnings CallTue, Aug 02, 2022 · 8:30 AM ETReplay
Surgery Partners (NASDAQ:SGRY) Q1 2022 Earnings CallTue, May 03, 2022 · 8:30 AM ETReplay
Surgery Partners (NASDAQ:SGRY) Q4 2021 Earnings CallMon, Feb 28, 2022 · 5:00 PM ETReplay
Surgery Partners (NASDAQ:SGRY) Q3 2021 Earnings CallTue, Nov 02, 2021 · 5:00 PM ETReplay
Surgery Partners (NASDAQ:SGRY) Q2 2021 Earnings CallWed, Aug 04, 2021 · 8:30 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 9, 2026 · After close+1.1%
Q2 2026Aug 10, 2026 · Before open+2.7%
Q1 2026May 5, 2026 · Before open+0.4%
Q4 2025Mar 2, 2026−10.2%
Q3 2025Nov 10, 2025 · Before open−25.4%
Q2 2025Aug 5, 2025 · Before open−0.3%
Q1 2025May 12, 2025 · Before open+5.0%
Q4 2024Feb 24, 2025 · Before open−0.6%
Q3 2024Nov 12, 2024 · Before open−5.9%
Q2 2024Aug 6, 2024 · Before open+3.2%
All 20 quarters
QuarterResultsShare move
Q1 2024May 7, 2024 · Before open+8.5%
Q4 2023Feb 26, 2024 · Before open−8.6%
Q3 2023Nov 7, 2023 · Before open+14.0%
Q2 2023Aug 1, 2023 · Before open−4.4%
Q1 2023May 1, 2023 · After close−5.6%
Q4 2022Mar 1, 2023 · Before open+1.6%
Q3 2022Nov 8, 2022 · Before open−2.4%
Q2 2022Aug 2, 2022 · Before open−7.4%
Q1 2022May 3, 2022 · Before open+7.2%
Q4 2021Feb 28, 2022 · After close+4.2%

Open Events

Decks

DeckKindSlidesDate
Q2 2026 Earnings PresentationEarnings9 slidesAug 10, 2026
Q1 2026 Earnings PresentationEarnings7 slidesMay 5, 2026
Q4 2025 Earnings PresentationEarnings8 slidesMar 3, 2026
42nd Annual J.P. Morgan Healthcare Conference (January 2024)Conference35 slidesJanuary 2024
41st Annual J.P. Morgan HealthCare Conference (January 2023)Conference34 slidesJanuary 2023
40th Annual J.P. Morgan Healthcare Conference (January 2022)Conference42 slidesJanuary 2022
Investor Presentation (August 2021)Investor deck45 slidesAugust 2021
Debt Investor Presentation (April 2021)Debt investors19 slidesApr 20, 2021
39th Annual J.P. Morgan Healthcare Conference (January 2021)Conference50 slidesJanuary 2021
Debt Investor Presentation (July 2020)Debt investors32 slidesJul 22, 2020
All 19 decks
DeckKindSlidesDate
Debt Investor Presentation (July 2020)Debt investors28 slidesJul 22, 2020
38th Annual J.P. Morgan Healthcare Conference (January 2020)Conference31 slidesJan 13, 2020
Debt Investor Presentation (March 2019)Debt investors24 slidesMar 25, 2019
Debt Investor Presentation (March 2019)Debt investors24 slidesMarch 2019
37th Annual J.P. Morgan Healthcare Conference (January 2019)Conference14 slidesJanuary 2019
Debt Investor Presentation (October 2018)Debt investors21 slidesOctober 2018
Debt Investor Presentation (May 2017)Debt investors44 slidesMay 23, 2017
Debt Investor Presentation (March 2016)Debt investors32 slidesMar 18, 2016
Debt Investor Presentation (March 2016)Debt investors8 slidesMar 14, 2016

Open Decks

Financings

RaiseDate
7.250% senior unsecured notes due 2032 (add-on notes)
Update: US$425M
Use of proceeds: General corporate purposes, including repaying outstanding borrowings under its revolving credit facility
Dec 11, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$19.00 a share on Sep 30, 2015.

Price
US$19.00 a share
Shares offered
14,285,000 shares of common stock
Offering size
US$271.4 million
Underwriters' option
Up to 2,142,750 more shares
Underwriters
BofA Merrill Lynch, Goldman, Sachs & Co., Jefferies, Citigroup, Morgan Stanley, Credit Suisse, Raymond James, RBC Capital Markets, Stifel · In the order on the cover
Shares delivered
On or about Oct 6, 2015

Steps

StepWhen
Draft sent to the SEC in confidenceApr 22, 2015
Filed publiclyAug 17, 2015
Amended twiceNewest Sep 21, 2015
Shares registered with an exchangeSep 28, 2015
Declared effective by the SECSep 30, 2015
Final prospectus, with the priceOct 2, 2015

Open IPO · From the cover of the final prospectus (424B4) filed Oct 2, 2015

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue3.31B3.11B2.74B2.54B2.23B1.86B1.83B1.77B1.34B1.15B
Cost of revenue2.54B2.37B2.10B1.96B1.73B1.48B1.41B1.36B1.01B821.2M
Gross profit765.0M745.6M647.5M574.9M491.4M379.8M423.8M410.0M327.4M324.2M
Research and development000
Selling, general and administrative522.7M138.7M120.9M102.2M104.0M97.1M88.6M93.6M76.0M60.2M
Operating income389.5M348.8M328.0M345.2M302.2M183.0M235.9M77.8M158.2M196.5M
Depreciation and amortization176.0M152.6M118.1M114.8M98.8M94.8M76.5M67.4M51.9M39.6M
EBITDA565.5M501.4M446.1M460.0M401.0M277.8M312.4M145.2M210.2M236.0M
Interest expense272.6M201.7M193.0M234.9M221.0M201.8M178.9M147.0M117.7M100.6M
Income before tax116.9M147.1M135.0M110.3M81.2M-18.8M54.6M-69.2M82.3M92.2M
Income tax18.0M134.6M-300.0K23.3M10.5M-20.1M9.50M26.4M53.5M7.09M
Net income-77.9M-168.1M-11.9M-54.6M-70.9M-116.1M-74.8M-205.7M-53.0M9.45M
Earnings per share, basic-0.61-1.33-0.09-0.59-1.12-3.19-2.29-4.96-1.080.20
Earnings per share, diluted-0.61-1.33-0.09-0.59-1.12-3.19-2.29-4.960.20

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents239.9M269.5M195.9M282.9M389.9M317.9M92.7M184.3M174.9M69.7M
Short-term investments74.6M90.0M3.81M10.9M
Receivables602.2M579.1M496.4M456.3M430.2M382.2M326.9M307.6M295.6M220.6M
Inventory96.6M88.4M75.2M71.4M61.1M56.4M46.3M43.4M45.0M28.8M
Current assets1.15B1.12B895.0M921.0M946.1M801.5M525.5M588.3M563.2M362.0M
Property, plant and equipment1.16B953.8M854.7M821.0M426.3M398.5M204.3M
Goodwill5.19B5.07B4.33B4.14B3.91B3.47B3.40B3.38B3.35B1.56B
Total assets8.12B7.89B6.88B6.68B6.12B5.41B5.02B4.68B4.62B2.30B
Accounts payable208.7M208.7M171.8M151.6M124.9M100.2M96.7M83.3M84.7M49.8M
Current liabilities615.5M624.4M523.0M493.4M536.8M556.8M398.1M349.3M303.0M186.7M
Long-term debt3.60B3.27B2.70B2.56B2.88B2.79B2.52B2.27B2.13B1.41B
Total debt3.74B3.40B2.80B2.63B2.96B2.88B2.60B2.33B2.31B1.47B
Total liabilities4.59B4.25B3.51B3.40B3.82B3.79B3.32B4.68B4.62B2.30B
Shareholders' equity1.71B1.79B1.99B2.00B1.09B115.6M296.8M404.6M654.7M9.68M
Shares outstanding129.3M127.1M126.6M126.0M89.3M50.5M49.3M48.9M49.0M48.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations274.3M300.1M293.8M158.8M87.1M246.9M129.5M144.6M120.9M125.2M
Capital spending-78.7M-90.4M-88.8M-80.6M-57.6M-42.9M-73.6M-39.8M-29.6M-39.1M
Free cash flow195.6M209.7M205.0M78.2M29.5M204.0M55.9M104.8M91.3M86.1M
Cash from investing-246.6M-488.5M-225.6M-307.9M-331.7M-88.4M-85.2M-128.9M-783.4M-184.7M
Cash from financing-57.3M262.0M-155.2M42.1M316.3M66.7M-135.9M-6.30M767.7M71.3M
Dividends paid0-146.8M-5.10M-109.6M-121.2M-7.80M-1.32M-85.9M
Share buybacks854.3M-233.5M00-2.00M-2.00M0
Change in cash-29.6M73.6M-87.0M-107.0M71.7M225.2M-91.6M9.40M11.8M11.8M

Open Financials

Filings

FilingDateTypeFiled with
DEFA14A · Additional proxy materialNov 18, 2026Meeting noticeSEC
8-K · Current reportNov 18, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
DEFA14A · Additional proxy materialNov 16, 2026Meeting noticeSEC
8-K · Current reportNov 16, 2026Current reportSEC
10-Q · Quarterly reportNov 9, 2026Quarterly reportSEC
DEFA14A · Additional proxy materialNov 9, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialNov 9, 2026Meeting noticeSEC
8-K · Current reportNov 9, 2026ResultsSEC
DEFA14A · Additional proxy materialNov 9, 2026Meeting noticeSEC
Show 200 filings
FilingDateTypeFiled with
8-K · Current reportNov 9, 2026Material contractSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 6, 2026Big-stake noticeSEC
DEFA14A · Additional proxy materialOct 28, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialOct 27, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialOct 26, 2026Meeting noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 26, 2026Big-stake noticeSEC
DEFA14A · Additional proxy materialOct 26, 2026Meeting noticeSEC
8-K · Current reportOct 26, 2026Material contractSEC
SCHEDULE 13G · Big-stake noticeOct 13, 2026Big-stake noticeSEC
8-K · Current reportSep 17, 2026Acquisition or disposalSEC
4/A · Change in ownership, amendedAug 20, 2026Insider tradeSEC
4 · Change in ownershipAug 19, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeAug 14, 2026Big-stake noticeSEC
10-Q · Quarterly reportAug 10, 2026Quarterly reportSEC
8-K · Current reportAug 10, 2026ResultsSEC
8-K · Current reportJul 24, 2026Material contractSEC
4 · Change in ownershipJul 14, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
8-K · Current reportJun 5, 2026Meeting outcomeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 6, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 5, 2026Quarterly reportSEC
8-K · Current reportMay 5, 2026ResultsSEC
DEFA14A · Additional proxy materialApr 23, 2026Meeting noticeSEC
ARS · Annual report to shareholdersApr 23, 2026Annual reportSEC
DEF 14A · Proxy statementApr 23, 2026Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 27, 2026Big-stake noticeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
144 · Notice of proposed saleMar 16, 2026Other filingsSEC
144 · Notice of proposed saleMar 16, 2026Other filingsSEC
144 · Notice of proposed saleMar 13, 2026Other filingsSEC
144 · Notice of proposed saleMar 13, 2026Other filingsSEC
144 · Notice of proposed saleMar 12, 2026Other filingsSEC
144 · Notice of proposed saleMar 12, 2026Other filingsSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 9, 2026Insider tradeSEC
144 · Notice of proposed saleMar 6, 2026Other filingsSEC
144 · Notice of proposed saleMar 6, 2026Other filingsSEC
144 · Notice of proposed saleMar 6, 2026Other filingsSEC
144 · Notice of proposed saleMar 6, 2026Other filingsSEC
144 · Notice of proposed saleMar 6, 2026Other filingsSEC
144 · Notice of proposed saleMar 6, 2026Other filingsSEC
144 · Notice of proposed saleMar 5, 2026Other filingsSEC
10-K · Annual reportMar 2, 2026Annual reportSEC
8-K · Current reportMar 2, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 5, 2026Big-stake noticeSEC
4 · Change in ownershipJan 15, 2026Insider tradeSEC
3 · Initial statement of ownershipJan 9, 2026Insider tradeSEC
8-K · Current reportDec 16, 2025Material contractSEC
8-K · Current reportDec 11, 2025Current reportSEC
8-K · Current reportDec 11, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeNov 14, 2025Big-stake noticeSEC
8-K · Current reportNov 12, 2025Management or board changeSEC
10-Q · Quarterly reportNov 10, 2025Quarterly reportSEC
8-K · Current reportNov 10, 2025ResultsSEC
144 · Notice of proposed saleOct 24, 2025Other filingsSEC
144 · Notice of proposed saleOct 23, 2025Other filingsSEC
144 · Notice of proposed saleOct 22, 2025Other filingsSEC
144 · Notice of proposed saleOct 21, 2025Other filingsSEC
144 · Notice of proposed saleOct 20, 2025Other filingsSEC
144 · Notice of proposed saleOct 16, 2025Other filingsSEC
144 · Notice of proposed saleOct 15, 2025Other filingsSEC
144 · Notice of proposed saleOct 14, 2025Other filingsSEC
144 · Notice of proposed saleOct 9, 2025Other filingsSEC
144 · Notice of proposed saleOct 8, 2025Other filingsSEC
144 · Notice of proposed saleSep 29, 2025Other filingsSEC
144 · Notice of proposed saleSep 26, 2025Other filingsSEC
144 · Notice of proposed saleSep 23, 2025Other filingsSEC
144 · Notice of proposed saleSep 22, 2025Other filingsSEC
144 · Notice of proposed saleSep 19, 2025Other filingsSEC
144 · Notice of proposed saleSep 18, 2025Other filingsSEC
144 · Notice of proposed saleSep 17, 2025Other filingsSEC
144 · Notice of proposed saleSep 16, 2025Other filingsSEC
8-K · Current reportSep 16, 2025Management or board changeSEC
144 · Notice of proposed saleSep 12, 2025Other filingsSEC
144 · Notice of proposed saleSep 11, 2025Other filingsSEC
144 · Notice of proposed saleSep 8, 2025Other filingsSEC
4 · Change in ownershipSep 8, 2025Insider tradeSEC
144 · Notice of proposed saleSep 5, 2025Other filingsSEC
144 · Notice of proposed saleSep 4, 2025Other filingsSEC
144 · Notice of proposed saleSep 4, 2025Other filingsSEC
144 · Notice of proposed saleSep 3, 2025Other filingsSEC
144 · Notice of proposed saleSep 2, 2025Other filingsSEC
144 · Notice of proposed saleAug 27, 2025Other filingsSEC
144 · Notice of proposed saleAug 26, 2025Other filingsSEC
144 · Notice of proposed saleAug 21, 2025Other filingsSEC
4/A · Change in ownership, amendedAug 15, 2025Insider tradeSEC
4 · Change in ownershipAug 15, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeAug 14, 2025Big-stake noticeSEC
8-K · Current reportAug 13, 2025Material contractSEC
4 · Change in ownershipAug 13, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 12, 2025Big-stake noticeSEC
144 · Notice of proposed saleAug 11, 2025Other filingsSEC
4 · Change in ownershipAug 8, 2025Insider tradeSEC
144 · Notice of proposed saleAug 8, 2025Other filingsSEC
UPLOAD · Letter from the SECAug 7, 2025Other filingsSEC
8-K · Current reportAug 6, 2025Management or board changeSEC
10-Q · Quarterly reportAug 5, 2025Quarterly reportSEC
8-K · Current reportAug 5, 2025ResultsSEC
CORRESP · Letter to the SECJul 17, 2025Other filingsSEC
UPLOAD · Letter from the SECJul 10, 2025Other filingsSEC
CORRESP · Letter to the SECJul 8, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 7, 2025Big-stake noticeSEC
UPLOAD · Letter from the SECJun 26, 2025Other filingsSEC
SCHEDULE 13D/A · Big-stake notice, amendedJun 17, 2025Big-stake noticeSEC
8-K · Current reportJun 17, 2025Current reportSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
S-8 · Registration statement for employee plansJun 10, 2025Offer documentSEC
8-K · Current reportJun 6, 2025Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 12, 2025Quarterly reportSEC
SCHEDULE 13G · Big-stake noticeMay 12, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 12, 2025Big-stake noticeSEC
8-K · Current reportMay 12, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 29, 2025Big-stake noticeSEC
ARS · Annual report to shareholdersApr 24, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 24, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 24, 2025Meeting noticeSEC
4 · Change in ownershipMar 25, 2025Insider tradeSEC
4 · Change in ownershipMar 17, 2025Insider tradeSEC
4 · Change in ownershipMar 17, 2025Insider tradeSEC
4 · Change in ownershipMar 17, 2025Insider tradeSEC
144 · Notice of proposed saleMar 14, 2025Other filingsSEC
144 · Notice of proposed saleMar 14, 2025Other filingsSEC
144 · Notice of proposed saleMar 14, 2025Other filingsSEC
4 · Change in ownershipMar 13, 2025Insider tradeSEC
4 · Change in ownershipMar 13, 2025Insider tradeSEC
4 · Change in ownershipMar 13, 2025Insider tradeSEC
4 · Change in ownershipMar 13, 2025Insider tradeSEC
4 · Change in ownershipMar 13, 2025Insider tradeSEC
4 · Change in ownershipMar 13, 2025Insider tradeSEC
144 · Notice of proposed saleMar 10, 2025Other filingsSEC
144 · Notice of proposed saleMar 10, 2025Other filingsSEC
144 · Notice of proposed saleMar 10, 2025Other filingsSEC
144 · Notice of proposed saleMar 10, 2025Other filingsSEC
144 · Notice of proposed saleMar 10, 2025Other filingsSEC
144 · Notice of proposed saleMar 10, 2025Other filingsSEC
10-K · Annual reportMar 6, 2025Annual reportSEC
4 · Change in ownershipMar 6, 2025Insider tradeSEC
4 · Change in ownershipMar 6, 2025Insider tradeSEC
4 · Change in ownershipMar 6, 2025Insider tradeSEC
4 · Change in ownershipMar 6, 2025Insider tradeSEC
4 · Change in ownershipMar 6, 2025Insider tradeSEC
4 · Change in ownershipMar 6, 2025Insider tradeSEC
4 · Change in ownershipMar 6, 2025Insider tradeSEC
NT 10-K · Late filing noticeMar 4, 2025Explanation requestSEC
8-K · Current reportMar 3, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 12, 2025Big-stake noticeSEC
4 · Change in ownershipFeb 10, 2025Insider tradeSEC
4 · Change in ownershipFeb 10, 2025Insider tradeSEC
4 · Change in ownershipFeb 10, 2025Insider tradeSEC
4 · Change in ownershipFeb 10, 2025Insider tradeSEC
4 · Change in ownershipFeb 10, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 10, 2025Big-stake noticeSEC
144 · Notice of proposed saleFeb 7, 2025Other filingsSEC
144 · Notice of proposed saleFeb 7, 2025Other filingsSEC
144 · Notice of proposed saleFeb 7, 2025Other filingsSEC
144 · Notice of proposed saleFeb 7, 2025Other filingsSEC
144 · Notice of proposed saleFeb 7, 2025Other filingsSEC
144 · Notice of proposed saleFeb 7, 2025Other filingsSEC
4 · Change in ownershipFeb 4, 2025Insider tradeSEC
4 · Change in ownershipFeb 4, 2025Insider tradeSEC
4 · Change in ownershipFeb 4, 2025Insider tradeSEC
4 · Change in ownershipFeb 4, 2025Insider tradeSEC
4 · Change in ownershipFeb 4, 2025Insider tradeSEC

This page holds 200 of 859 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Surgery Partners, Inc.’s releases · as of Nov 2, 2026

Common shares
130,881,223
Fully diluted
130,881,223

Fully diluted

LineSharesAs of
Common shares130,881,223Nov 2, 2026

Share count over time

CountShares
Nov 2, 2026130,881,223

Open Cap table

Shareholders

Institutions

HolderSharesValueAs of
Bain Capital Investors LLC49.9MUS$693MSep 30, 2026
Janus Henderson13.3MUS$185MSep 30, 2026
Pentwater Capital Management LP10.9MUS$151MSep 30, 2026
UBS10.8MUS$150MSep 30, 2026
Vanguard7.87MUS$109MSep 30, 2026
BlackRock6.65MUS$92.2MSep 30, 2026
Glenview Capital Management, LLC6.52MUS$90.4MSep 30, 2026
Dimensional5.91MUS$82MSep 30, 2026
HSBC3.08MUS$43.9MSep 30, 2026
Franklin Templeton2.97MUS$41.2MSep 30, 2026
Show 50 holders
HolderSharesValueAs of
Davidson Kempner Capital Management LP2.74MUS$38MSep 30, 2026
Nomura2.69MUS$37.3MSep 30, 2026
State Street2.25MUS$31.2MSep 30, 2026
Geode Capital1.8MUS$24.9MSep 30, 2026
BROOKFIELD Corp1.61MUS$22.4MSep 30, 2026
Hein Park Capital Management LP1.38MUS$19.1MSep 30, 2026
Schwab1.34MUS$18.5MSep 30, 2026
Whitefort Capital Management, LP1.32MUS$18.3MSep 30, 2026
Fidelity1.27MUS$17.6MSep 30, 2026
Morgan Stanley1.14MUS$15.8MSep 30, 2026
Victory Capital1.05MUS$14.5MSep 30, 2026
Sirios Capital Management L P1.01MUS$14MSep 30, 2026
Bank of America973KUS$13.5MSep 30, 2026
Balyasny Asset Management L.P.833KUS$11.6MSep 30, 2026
Northern Trust736KUS$10.2MSep 30, 2026
Goldman Sachs628KUS$8.72MSep 30, 2026
Citadel550KUS$7.63MSep 30, 2026
Arrowstreet Capital, Limited Partnership531KUS$7.36MSep 30, 2026
Dimension Capital Management LLC451KUS$6.25MSep 30, 2026
Man Group plc437KUS$6.06MSep 30, 2026
Barclays423KUS$5.87MSep 30, 2026
BNP Paribas403KUS$5.59MSep 30, 2026
AQR Capital Management LLC383KUS$5.31MSep 30, 2026
BNY318KUS$4.41MSep 30, 2026
Kennedy Capital Management LLC279KUS$3.87MSep 30, 2026
Marshall Wace, LLP276KUS$3.83MSep 30, 2026
Tudor Investment Corp Et Al273KUS$3.79MSep 30, 2026
Verition Fund Management LLC257KUS$3.57MSep 30, 2026
Hudson Bay Capital Management LP236KUS$3.27MSep 30, 2026
Invesco213KUS$2.96MSep 30, 2026
Principal208KUS$2.89MSep 30, 2026
TD197KUS$2.6MSep 30, 2026
Quantinno Capital Management LP192KUS$2.66MSep 30, 2026
Zacks Investment Management192KUS$2.66MSep 30, 2026
Nuveen187KUS$2.59MSep 30, 2026
Swiss National Bank159KUS$2.2MSep 30, 2026
Corient Private Wealth LP159KUS$2.2MSep 30, 2026
CastleKnight Management LP150KUS$2.09MSep 30, 2026
Allianz140KUS$1.94MSep 30, 2026
LMR Partners LLP137KUS$1.9MSep 30, 2026

This page holds 50 of 184 holders. Open Shareholders

Funds

HolderSharesValueAs of
Janus Henderson Contrarian Fund13.3MUS$223MJun 30, 2026
Vanguard Total Stock Market Index Fund2.48MUS$41.7MJun 30, 2026
T. Rowe Price Small-Cap Stock Fund, Inc.2.1MUS$35.2MJun 30, 2026
iShares Russell 2000 ETF2.08MUS$35MJun 30, 2026
Vanguard Small-Cap Index Fund1.8MUS$30.2MJun 30, 2026
ClearBridge Select Fund1.59MUS$24.6MJul 31, 2026
U.S. Small Cap Value Portfolio1.4MUS$21.5MJul 31, 2026
ClearBridge Small Cap Growth Fund1.24MUS$19MJul 31, 2026
Vanguard Small-Cap Value Index Fund1.14MUS$19.2MJun 30, 2026
T. Rowe Price Institutional Small-Cap Stock Fund1.13MUS$19MJun 30, 2026
Show 50 holders
HolderSharesValueAs of
Select Health Care Services Portfolio1.06MUS$14.1MMay 31, 2026
Vanguard Extended Market Index Fund883KUS$14.8MJun 30, 2026
Fidelity Small Cap Index Fund874KUS$13.5MJul 31, 2026
iShares Russell 2000 Value ETF738KUS$12.4MJun 30, 2026
T. Rowe Price Small-Cap Value Fund, Inc.701KUS$11.8MJun 30, 2026
Focused Growth Portfolio586KUS$9.85MJun 30, 2026
Dimensional US Small Cap Value ETF569KUS$8.76MJul 31, 2026
Dimensional U.S. Targeted Value ETF567KUS$8.73MJul 31, 2026
U.S. Small Cap Portfolio521KUS$8.03MJul 31, 2026
U.S. Targeted Value Portfolio398KUS$6.12MJul 31, 2026
Vanguard Russell 2000 Index Fund397KUS$5.31MMay 31, 2026
Fidelity Extended Market Index Fund395KUS$5.28MMay 31, 2026
Schwab U.S. Small-Cap ETF366KUS$4.89MMay 31, 2026
Strategic Advisers Fidelity U.S. Total Stock Fund365KUS$4.87MMay 31, 2026
Schwab Fundamental U.S. Small Company ETF333KUS$4.45MMay 31, 2026
Dimensional U.S. Small Cap ETF331KUS$5.1MJul 31, 2026
Victory Integrity Small-Cap Value Fund321KUS$5.39MJun 30, 2026
ClearBridge Variable Small Cap Growth Portfolio271KUS$4.56MJun 30, 2026
U.S. Micro Cap Portfolio264KUS$4.07MJul 31, 2026
Vanguard Health Care Index Fund234KUS$3.13MMay 31, 2026
Fidelity High Income Fund227KUS$3.49MJul 31, 2026
Fidelity SAI High Income Fund212KUS$3.27MJul 31, 2026
Schwab Small-Cap Index Fund194KUS$2.99MJul 31, 2026
Invesco RAFI US 1500 Small-Mid ETF161KUS$2.49MJul 31, 2026
State Street(R) SPDR(R) S&P(R) Health Care Services ETF159KUS$2.67MJun 30, 2026
Master Small Cap Index Series149KUS$2.51MJun 30, 2026
EQ/ClearBridge Select Equity Managed Volatility Portfolio149KUS$2.5MJun 30, 2026
Principal U.S. Small-Cap ETF148KUS$2.48MJun 30, 2026
U.S. Core Equity 2 Portfolio146KUS$2.25MJul 31, 2026
Fidelity Total Market Index Fund139KUS$1.86MMay 31, 2026
iShares U.S. Healthcare Providers ETF138KUS$2.33MJun 30, 2026
Dimensional U.S. Core Equity 2 ETF138KUS$2.13MJul 31, 2026
Fidelity Series Total Market Index Fund115KUS$1.54MMay 31, 2026
Fidelity Small Cap Value Index Fund112KUS$1.88MJun 30, 2026
iShares Core S&P Total U.S. Stock Market ETF108KUS$1.81MJun 30, 2026
Schwab Fundamental U.S. Small Company Index Fund107KUS$1.65MJul 31, 2026
Nuveen Small Cap Blend Index Fund106KUS$1.64MJul 31, 2026
EQ/2000 Managed Volatility Portfolio87,043US$1.46MJun 30, 2026
Fidelity Nasdaq Composite Index Fund78,273US$1.05MMay 31, 2026
Fidelity Series High Income Fund67,800US$1.04MJul 31, 2026

This page holds 50 of 187 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
DeLuca Teresa
Director
Buy11,250USD 14.33US$161KAug 18, 2026
DeLuca Teresa
Director
Buy10,000USD 14.35US$144KAug 18, 2026

Big stakes

StakeStakeSharesDateFiling
Pentwater Capital Management LP8.30%10.9MSep 30, 2026Schedule 13G
BCPE Seminole Holdings LP8.18%10.7MOct 23, 2026Schedule 13D
GLENVIEW CAPITAL MANAGEMENT, LLC5.40%7.02MOct 6, 2026Schedule 13G
Janus Henderson Group PLC4.90%6.42MOct 30, 2026Schedule 13G
King Street Capital Management, L.P.4.60%6.06MJun 30, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Lloyd Dean
Other companies: Progyny, Inc. (Director · Since at least Aug 30, 2022); McDonald's Corporation (Director · Since at least Sep 30, 2017); Bolt Projects Holdings, Inc. (Director · Aug 13, 2024 – Aug 13, 2024 · Past); Golden Arrow Merger Corp (Director · Mar 16, 2021 – Mar 16, 2021 · Past); Wells Fargo & Company (Director · Oct 1, 2017 – Apr 1, 2018 · Past)
Director · Since at least Feb 26, 2026
Wayne S. DeVeydt
Other companies: UnitedHealth Group Incorporated (Chief Financial Officer · Since at least Jul 31, 2025); Centene Corporation (Director · Since at least Jan 5, 2022); Myovant Sciences Ltd (Director · Oct 26, 2016 – Aug 18, 2017 · Past); NiSource Inc (Director · Mar 22, 2016 – May 25, 2021 · Past); Elevance Health, Inc. (EVP & Chief Financial Officer · Mar 1, 2006 – Mar 3, 2016 · Past)
Exec Chairman of the Board, Director · Jan 4, 2018 – Mar 21, 2025 · Past
Adam T Feinstein
Other companies: AirSculpt Technologies, Inc. (Director · Since at least Oct 28, 2021); Quorum Health Corporation (Director · Apr 19, 2016 – Apr 28, 2017 · Past)
Director · Sep 30, 2015 – May 20, 2019 · Past
Patricia Anne Maryland
Other companies: Encompass Health Corporation (Director · Since at least Jan 1, 2020); Privia Health Group, Inc. (Director · Apr 28, 2021 – May 21, 2025 · Past)
Director · Since at least Mar 10, 2021
Teresa DeLuca
Other companies: LifeStance Health Group, Inc. (Director · Since at least Mar 12, 2024); Forum Markets, Incorporated (Director · Jul 9, 2021 – Sep 4, 2023 · Past)
Director · Since at least Sep 30, 2016
Andrew Kaplan
Other companies: Kailera Therapeutics, Inc. (Partner, Bain Capital Private Equity · Since at least Apr 16, 2026)
Director · Aug 31, 2018 – Dec 19, 2023 · Past
Blair E Hendrix
Other companies: iHeartMedia, Inc. (Director · May 1, 2019 – May 1, 2019 · Past)
Director · Since at least Nov 23, 2022
Devin O'Reilly
Other companies: Aveanna Healthcare Holdings Inc. (Compensation Committee Chair · Since at least Apr 28, 2021)
Director · May 17, 2021 – Dec 19, 2023 · Past
Jason Eric Evans
Other companies: Teladoc Health, Inc. (Director · Since at least Sep 20, 2023)
Chief Executive Officer · Since at least Feb 24, 2021
Laura L. Forese
Other companies: Cantel Medical Corp (Director · Mar 19, 2015 – Jun 2, 2021 · Past)
Director · Since at least Jan 10, 2025
All 51 people
PersonSeat
Sarath Degala
Other companies: Privia Health Group, Inc. (Chief Operating Officer · Since at least Nov 4, 2026)
Chief Development Officer · May 23, 2016 – Oct 3, 2016 · Past
Thomas F Cowhey
Other companies: CVS Health Corporation (EVP and CFO · Oct 13, 2023 – Apr 1, 2025 · Past)
Chief Financial Officer · Apr 2, 2018 – May 6, 2021 · Past
Anthony TaparoChief Growth Officer · Apr 19, 2018 – Mar 11, 2024 · Past
Benjamin F JacobsCDO, Grp Pres of SP · Aug 31, 2017 – Aug 31, 2017 · Past
Bradley R OwensNational Group President · Jan 1, 2021 – May 31, 2024 · Past
Brandan LinglePres., Ancillary Svces. Grp. · Apr 19, 2018 – Mar 31, 2019 · Past
Brent JacobsSenior Vice President – Acquisitions and Development · Since at least Nov 4, 2026
Brent TurnerDirector · Since at least Jun 10, 2025
Bryan S FisherEVP, COO of SP Ntl Grp · Aug 31, 2017 – Aug 31, 2018 · Past
Cameron EadesSenior Vice President – Controller · Since at least Nov 4, 2026
Carollee BrinkmanPresident, National Group · Mar 15, 2019 – Mar 15, 2019 · Past
Christopher LaitalaDirector · Sep 30, 2015 – Apr 20, 2016 · Past
Clifford G AdlerzDirector · Since at least Sep 7, 2017
Danielle BurkhalterExecutive Vice President – Chief People and Transformation Officer · Since at least Jan 19, 2023
Dave DohertyExecutive Vice President – Chief Financial Officer · Since at least Aug 10, 2026
David T DohertyChief Financial Officer · Since at least Feb 1, 2022
Dawn CastroSenior Vice President – Chief Revenue Cycle Officer · Since at least Nov 4, 2026
Eric EvansChief Executive Officer · Since at least Oct 26, 2026
Harrison R BaneNational Group President · Since at least Sep 30, 2022
Jackie WrightSenior Vice President – Chief Procurement Officer · Since at least Nov 4, 2026
Jane VanderbiltSenior Vice President – Business Operations · Since at least Nov 4, 2026
Jennifer BaldockExecutive Vice President – Chief Administrative and Development Officer · Since at least Dec 8, 2025
Jeremy ClarkNorth Division, President · Since at least Nov 4, 2026
John A DeaneDirector · Since at least May 29, 2019
Jon FredricksonSenior Vice President – Chief Information Officer · Since at least Nov 4, 2026
Justin OppenheimerExecutive Vice President – Chief Operating Officer · Since at least Jan 1, 2026
Kelly T. WhelanSenior Vice President – General Counsel · Since at least Nov 4, 2026
Kristi JensenMarket CEO (Northeast) and Enterprise Operational Excellence · Since at least Nov 4, 2026
Laura L BrocklehurstChief Human Resources Officer · Jan 1, 2021 – Nov 9, 2022 · Past
Marissa BrittenhamExecutive Vice President – Chief Strategy Officer · Since at least Jan 10, 2022
Mike MaleyWest Division, President · Since at least Nov 4, 2026
Noah ClevengerMarket CEO (Illinois) and Enterprise Preferred Vascular · Since at least Nov 4, 2026
Patrick BrownSenior Vice President – Market Growth and Business Development · Since at least Nov 4, 2026
Roxanne WomackSenior Vice President – Chief Compliance Officer · Since at least Nov 4, 2026
Shannon YarrowSenior Vice President – Managed Care · Since at least Nov 4, 2026
Sid SoonasraSenior Vice President - Physician Practice and Anesthesia Operations · Since at least Nov 4, 2026
Spencer ClarkSenior Vice President – General Counsel · Since at least Nov 4, 2026
Steven CornelisonSenior Vice President – Treasurer · Since at least Nov 4, 2026
Tamala Norris-McJunkinsSenior Vice President – Enterprise Chief Clinical Officer · Since at least Nov 4, 2026
Trent WebbSouth Division, President · Since at least Nov 4, 2026
William Trenton WebbAmerican Group President · Since at least Sep 1, 2024

Open People

Log in to ask 6ix AI your own questions about Surgery Partners, Inc.